Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Incyte
Company Monitoring Page for Incyte
latest headlines for company on cafepharma
Forget Incyte: Gilead Sciences Would Be Better Off Buying This Company
Motley Fool
Wed, 01/25/17 - 09:53 am
Tags:
Gilead Sciences
,
Incyte
,
M&A
,
Galapagos
FDA delays decision on Lilly and Incyte's arthritis drug
BioPharma Dive
Tue, 01/17/17 - 11:04 am
Tags:
FDA
,
Eli Lilly
,
Incyte
,
rheumatoid arthritis
,
baricitinib
What Were Incyte’s Revenue Streams in 3Q16?
Market Realist
Sat, 01/7/17 - 12:38 pm
Tags:
Incyte
,
Jakafi
,
Iclusig
Biotech Investing: 3 Bold Predictions for 2017
Motley Fool
Fri, 01/6/17 - 09:47 am
Tags:
biotech
,
Incyte
,
Biogen
,
Biomarin
,
Gilead Sciences
,
Illumina
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
Tags:
biotech
,
M&A
,
drug launches
,
Gilead Sciences
,
Incyte
,
Spinraza
,
Biogen
,
Ionis Pharmaceuticals
,
Amgen
,
Regeneron
,
Sanofi
The Most Likely Incyte Acquisition Deal for 2017?
Motley Fool
Sat, 12/24/16 - 12:11 pm
Tags:
M&A
,
Incyte
,
Gilead Sciences
,
Lilly
,
Novartis
,
Agenus
Incyte puts up $200M in bispecifics deal with Merus
BioPharma Dive
Thu, 12/22/16 - 10:21 am
Tags:
Incyte
,
Merus
,
bispecific antibodies
Gilead Fails to Beat Incyte’s Jakafi Drug
Investopedia
Sat, 11/19/16 - 11:32 am
Tags:
Gilead Sciences
,
Jakafi
,
Incyte
,
momelotinib
,
myelofibrosis
Should Gilead Sciences Purchase Incyte?
Seeking Alpha
Fri, 11/18/16 - 10:02 am
Tags:
Gilead Sciences
,
Incyte
,
M&A
3 Biotechs Most Likely to Be Acquired
Motley Fool
Tue, 10/11/16 - 09:45 pm
Tags:
biotech
,
M&A
,
Incyte
,
Biomarin
,
Biogen
Updated Incyte combo data for epacadostat/Keytruda look promising
Endpoints
Fri, 10/7/16 - 09:09 am
Tags:
Incyte
,
epacadostat
,
Keytruda
Incyte Could Be A Takeover Target, Argus Lifts Price Target To $98
Yahoo/Benzinga
Tue, 09/27/16 - 10:04 pm
Tags:
Incyte
,
M&A
After Losing Medivation, Who Is Gilead Going After Next?
Forbes
Mon, 09/19/16 - 03:39 pm
Tags:
Medivation
,
Gilead Sciences
,
M&A
,
Puma Biotechnology
,
Kite Pharma
,
Incyte
,
Portola Pharmaceuticals
3 Biotech Stocks Could Be the Next Big Takeover Targets
24/7 Wall St
Wed, 08/31/16 - 09:20 am
Tags:
biotech
,
M&A
,
Biomarin
,
Incyte
,
Tesaro
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss
Barron's
Tue, 08/23/16 - 11:11 am
Tags:
biotech
,
M&A
,
Gilead Sciences
,
Sanofi
,
Medivation
,
Incyte
,
Biomarin
,
Tesaro
,
Seattle Genetics
3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
Tue, 07/5/16 - 10:20 am
Tags:
biotech
,
Acadia
,
AstraZeneca
,
Allergan
,
Biogen
,
Teva Pharmaceutical
,
Biomarin
,
Incyte
,
Ironwood
,
Medivation
,
Pfizer
,
Relypsa
,
Synergy Pharmaceuticals
,
M&A
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
Tags:
biotech
,
M&A
,
Alder Biopharmaceuticals
,
Biomarin
,
Coherus Biosciences
,
Intercept Pharma
,
Ultragenyx
,
Seattle Genetics
,
Adamas Pharmaceuticals
,
Alexion
,
Clovis Oncology
,
Corbus Pharmaceuticals
,
Incyte
,
Prothena
,
Puma Biotechnology
,
Tesaro
,
Versartis
FDA Grants Breakthrough Therapy Designation for Incyte’s Ruxolitinib (Jakafi®) in Acute Graft-Versus-Host Disease (GVHD)
Yahoo
Fri, 06/24/16 - 09:15 am
Tags:
FDA
,
Incyte
,
Jakafi
,
breakthrough therapies
,
graft vs host disease
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
Yahoo
Thu, 06/9/16 - 10:10 am
Tags:
baricitinib
,
Eli Lilly
,
Incyte
,
rheumatoid arthritis
Biotech: Is the Rally Real?
Barron's
Thu, 06/2/16 - 04:01 pm
Tags:
biotech
,
Prothena
,
Biomarin
,
Vertex Pharmaceuticals
,
Incyte
,
Celgene
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.